back to article Medicxi launches $300m European late-stage life sciences fund backed by Google company

Venture capital group Medicxi has announced a $300m late-stage life sciences fund that is backed by Novartis, the European Investment Fund (EIF) and Verily Life Sciences, the healthcare division of Google's holding company Alphabet. The Medicxi Growth 1 (MG1) fund will invest in European biotechnology groups looking to run …

  1. John Smith 19 Gold badge
    Unhappy

    New fund bets on virtual certainties.

    Not called "vulture capitalists" for nothing.

POST COMMENT House rules

Not a member of The Register? Create a new account here.

  • Enter your comment

  • Add an icon

Anonymous cowards cannot choose their icon

Other stories you might like